Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald B Vender

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Drugs in Dermatology : JDD|August 19, 2016
Transitioning Between Brodalumab and Secukinumab in Moderate to Severe Psoriasis: An Early LookRonald B Vender
Journal of Cutaneous Medicine and Surgery|January 28, 2021
A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 PandemicHeather Le, Ronald B Vender
Journal of Drugs in Dermatology : JDD|February 9, 2005
Innovative uses of imiquimodRonald B Vender, Orli Goldberg
Journal of Cutaneous Medicine and Surgery|June 1, 2005
Antihistamines in the treatment of dermatitisSari M Herman, Ronald B Vender
Journal of Cutaneous Medicine and Surgery|April 16, 2013
Sulfa or sulfur? Clearing things upLisa Wenyang Fu, Ronald B Vender
Skin Therapy Letter|November 18, 2011
Newer approaches in topical combination therapy for acneLisa W Fu, Ronald B Vender
Journal of Cutaneous Medicine and Surgery|February 8, 2022
Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian CentersRonald B Vender, Charles W Lynde
Journal of Cutaneous Medicine and Surgery|January 24, 2007
Cutaneous reaction to drugs used for erectile dysfunction: case report and review of the literatureRenee A Beach, Frank Murphy, Ronald B Vender
Journal of Cutaneous Medicine and Surgery|March 17, 2015
Public Engagement with Dermatology Contents on FacebookWhan B Kim, Joseph E C Marinas, Ronald B Vender
International Journal of Dermatology|May 29, 2024
From treatment to trigger: a systematic review of imiquimod-induced psoriasisNirmay Shah, Gursimran Deol, Eric McMullen, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Drugs in Dermatology : JDD|August 19, 2016
Transitioning Between Brodalumab and Secukinumab in Moderate to Severe Psoriasis: An Early LookRonald B Vender
Journal of Cutaneous Medicine and Surgery|January 28, 2021
A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 PandemicHeather Le, Ronald B Vender
Journal of Drugs in Dermatology : JDD|February 9, 2005
Innovative uses of imiquimodRonald B Vender, Orli Goldberg
Journal of Cutaneous Medicine and Surgery|June 1, 2005
Antihistamines in the treatment of dermatitisSari M Herman, Ronald B Vender
Journal of Cutaneous Medicine and Surgery|April 16, 2013
Sulfa or sulfur? Clearing things upLisa Wenyang Fu, Ronald B Vender
Skin Therapy Letter|November 18, 2011
Newer approaches in topical combination therapy for acneLisa W Fu, Ronald B Vender
Journal of Cutaneous Medicine and Surgery|February 8, 2022
Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian CentersRonald B Vender, Charles W Lynde
Journal of Cutaneous Medicine and Surgery|January 24, 2007
Cutaneous reaction to drugs used for erectile dysfunction: case report and review of the literatureRenee A Beach, Frank Murphy, Ronald B Vender
Journal of Cutaneous Medicine and Surgery|March 17, 2015
Public Engagement with Dermatology Contents on FacebookWhan B Kim, Joseph E C Marinas, Ronald B Vender
International Journal of Dermatology|May 29, 2024
From treatment to trigger: a systematic review of imiquimod-induced psoriasisNirmay Shah, Gursimran Deol, Eric McMullen, et al.
Pageof 3